BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32359011)

  • 1. Click-Chemistry (CuAAC) Trimerization of an α
    Quigley NG; Tomassi S; Di Leva FS; Di Maro S; Richter F; Steiger K; Kossatz S; Marinelli L; Notni J
    Chembiochem; 2020 Oct; 21(19):2836-2843. PubMed ID: 32359011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
    Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
    J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking a TGF-β activator in vivo: sensitive PET imaging of αvβ8-integrin with the Ga-68-labeled cyclic RGD octapeptide trimer Ga-68-Triveoctin.
    Quigley NG; Steiger K; Richter F; Weichert W; Hoberück S; Kotzerke J; Notni J
    EJNMMI Res; 2020 Oct; 10(1):133. PubMed ID: 33128636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.
    Notni J; Pohle K; Wester HJ
    Nucl Med Biol; 2013 Jan; 40(1):33-41. PubMed ID: 22995902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a
    Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
    Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic poly-chelator frameworks for multimeric bioconjugation.
    Reich D; Wurzer A; Wirtz M; Stiegler V; Spatz P; Pollmann J; Wester HJ; Notni J
    Chem Commun (Camb); 2017 Feb; 53(17):2586-2589. PubMed ID: 28191563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12.
    Quigley NG; Steiger K; Färber SF; Richter F; Weichert W; Notni J
    Mol Pharm; 2024 Apr; 21(4):1827-1837. PubMed ID: 38291706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.
    Baranyai Z; Reich D; Vágner A; Weineisen M; Tóth I; Wester HJ; Notni J
    Dalton Trans; 2015 Jun; 44(24):11137-46. PubMed ID: 25999035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
    Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.
    Wurzer A; Seidl C; Morgenstern A; Bruchertseifer F; Schwaiger M; Wester HJ; Notni J
    Chemistry; 2018 Jan; 24(3):547-550. PubMed ID: 28833667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
    Israel I; Richter D; Stritzker J; van Ooschot M; Donat U; Buck AK; Samnick S
    Curr Cancer Drug Targets; 2014; 14(4):371-9. PubMed ID: 24720338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.
    Notni J; Šimeček J; Wester HJ
    ChemMedChem; 2014 Jun; 9(6):1107-15. PubMed ID: 24700633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
    Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
    Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT Imaging of NSCLC with a α
    Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
    Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.
    Menichetti L; Kusmic C; Panetta D; Arosio D; Petroni D; Matteucci M; Salvadori PA; Casagrande C; L'Abbate A; Manzoni L
    Eur J Nucl Med Mol Imaging; 2013 Aug; 40(8):1265-74. PubMed ID: 23674206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides.
    Satpati D; Hausner SH; Bauer N; Sutcliffe JL
    J Labelled Comp Radiopharm; 2014 Jul; 57(9):558-65. PubMed ID: 25042833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
    Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
    Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.